90 related articles for article (PubMed ID: 27573585)
1. Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma.
Pruksakorn D; Teeyakasem P; Klangjorhor J; Chaiyawat P; Settakorn J; Diskul-Na-Ayudthaya P; Chokchaichamnankit D; Pothacharoen P; Srisomsap C
Int J Oncol; 2016 Sep; 49(3):903-12. PubMed ID: 27573585
[TBL] [Abstract][Full Text] [Related]
2. Proteomics and genomics insights on malignant osteosarcoma.
Kathiresan N; Selvaraj C; Pandian S; Subbaraj GK; Alothaim AS; Safi SZ; Kulathaivel L
Adv Protein Chem Struct Biol; 2024; 138():275-300. PubMed ID: 38220428
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma.
Zhou Y; Ray PS; Zhu J; Stein F; Rettel M; Sekaran T; Sahadevan S; Perez-Perri JI; Roth EK; Myklebost O; Meza-Zepeda LA; von Deimling A; Fu C; Brosig AN; Boye K; Nathrath M; Blattmann C; Lehner B; Hentze MW; Kulozik AE
Nat Commun; 2024 Apr; 15(1):2810. PubMed ID: 38561347
[TBL] [Abstract][Full Text] [Related]
4. Tandem mass tag (TMT) quantitative protein analysis-based proteomics and parallel reaction monitoring (PRM) validation revealed that MST4 accelerates osteosarcoma proliferation by increasing MRC2 activity.
Liu Y; Zhang X; Ren X; Sun J; Wen Y; Guo Z; Ma Q
Mol Carcinog; 2023 Sep; 62(9):1338-1354. PubMed ID: 37378424
[TBL] [Abstract][Full Text] [Related]
5. Comparative Shotgun Proteomics Reveals the Characteristic Protein Signature of Osteosarcoma Subtypes.
Alaa M; Al-Shehaby N; Anwar AM; Farid N; Shawky MS; Zamzam M; Zaky I; Elghounimy A; El-Naggar S; Magdeldin S
Cells; 2023 Aug; 12(17):. PubMed ID: 37681913
[TBL] [Abstract][Full Text] [Related]
6. KH-type splicing regulatory protein (KHSRP) contributes to tumorigenesis by promoting miR-26a maturation in small cell lung cancer.
Tong L; Luo Y; Wei T; Guo L; Wang H; Zhu W; Zhang J
Mol Cell Biochem; 2016 Nov; 422(1-2):61-74. PubMed ID: 27644194
[TBL] [Abstract][Full Text] [Related]
7. K-Homology Type Splicing Regulatory Protein: Mechanism of Action in Cancer and Immune Disorders.
Leavenworth JD; Yusuf N; Hassan Q
Crit Rev Eukaryot Gene Expr; 2024; 34(1):75-87. PubMed ID: 37824394
[TBL] [Abstract][Full Text] [Related]
8. Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction.
Sirikaew N; Pruksakorn D; Chaiyawat P; Chutipongtanate S
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077137
[TBL] [Abstract][Full Text] [Related]
9. The Role of KH-Type Splicing Regulatory Protein (KSRP) for Immune Functions and Tumorigenesis.
Palzer KA; Bolduan V; Käfer R; Kleinert H; Bros M; Pautz A
Cells; 2022 Apr; 11(9):. PubMed ID: 35563788
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis.
Peng LP; Li J; Li XF
World J Clin Cases; 2022 Mar; 10(7):2194-2205. PubMed ID: 35321179
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOTTIP facilitates cell proliferation, invasion, and migration in osteosarcoma by interaction with PTBP1 to promote KHSRP level.
Yao XY; Liu JF; Luo Y; Xu XZ; Bu J
Cell Cycle; 2021 Feb; 20(3):283-297. PubMed ID: 33475442
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma.
Chaiyawat P; Sirikaew N; Budprom P; Klangjorhor J; Phanphaisarn A; Teeyakasem P; Settakorn J; Pruksakorn D
J Bone Oncol; 2020 Dec; 25():100321. PubMed ID: 33072501
[TBL] [Abstract][Full Text] [Related]
13. In vitro drug sensitivity (IDS) of patient-derived primary osteosarcoma cells as an early predictor of the clinical outcomes of osteosarcoma patients.
Klangjorhor J; Phanphaisarn A; Teeyakasem P; Chaiyawat P; Phinyo P; Settakorn J; Theera-Umpon N; Pruksakorn D
Cancer Chemother Pharmacol; 2020 Jun; 85(6):1165-1176. PubMed ID: 32476109
[TBL] [Abstract][Full Text] [Related]
14. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
15. KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment.
Caiazza F; Oficjalska K; Tosetto M; Phelan JJ; Noonan S; Martin P; Killick K; Breen L; O'Neill F; Nolan B; Furney S; Power R; Fennelly D; Craik CS; O'Sullivan J; Sheahan K; Doherty GA; Ryan EJ
Am J Pathol; 2019 Oct; 189(10):1916-1932. PubMed ID: 31404541
[TBL] [Abstract][Full Text] [Related]
16. KSRP modulates melanoma growth and efficacy of vemurafenib.
Liu W; Chou CF; Liu S; Crossman D; Yusuf N; Wu Y; Chen CY
Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):759-770. PubMed ID: 31269460
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma.
Chaiyawat P; Pruksakorn D; Pipatwattana P; Phanphaisarn A; Teeyakasem P; Klangjorhor J; Settakorn J
J Bone Oncol; 2019 Jun; 16():100233. PubMed ID: 30984555
[TBL] [Abstract][Full Text] [Related]
18. Protein profiling of osteosarcoma tissue and soft callus unveils activation of the unfolded protein response pathway.
Chaiyawat P; Sungngam P; Teeyakasem P; Sirikaew N; Klangjorhor J; Settakorn J; Diskul-Na-Ayudthaya P; Chokchaichamnankit D; Srisomsap C; Svasti J; Pruksakorn D
Int J Oncol; 2019 May; 54(5):1704-1718. PubMed ID: 30816440
[TBL] [Abstract][Full Text] [Related]
19. PUF60 accelerates the progression of breast cancer through downregulation of PTEN expression.
Sun D; Lei W; Hou X; Li H; Ni W
Cancer Manag Res; 2019; 11():821-830. PubMed ID: 30697074
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
